KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Shares Repurchased (2016 - 2025)

Gilead Sciences' Shares Repurchased history spans 17 years, with the latest figure at $230.0 million for Q4 2025.

  • For Q4 2025, Shares Repurchased fell 34.29% year-over-year to $230.0 million; the TTM value through Dec 2025 reached $1.9 billion, up 67.13%, while the annual FY2025 figure was $1.9 billion, 67.13% up from the prior year.
  • Shares Repurchased reached $230.0 million in Q4 2025 per GILD's latest filing, down from $435.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $792.0 million in Q4 2022 to a low of $43.0 million in Q2 2021.
  • Average Shares Repurchased over 5 years is $300.7 million, with a median of $300.0 million recorded in 2023.
  • Peak YoY movement for Shares Repurchased: surged 1516.33% in 2022, then tumbled 81.06% in 2023.
  • A 5-year view of Shares Repurchased shows it stood at $49.0 million in 2021, then soared by 1516.33% to $792.0 million in 2022, then crashed by 81.06% to $150.0 million in 2023, then surged by 133.33% to $350.0 million in 2024, then tumbled by 34.29% to $230.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Shares Repurchased are $230.0 million (Q4 2025), $435.0 million (Q3 2025), and $527.0 million (Q2 2025).